USBC Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeP/E ratio—
EPS (TTM)$-0.390.0% YoY
Profit margin0.0%TECHNOLOGY
Market cap$168.8MMicro cap
Valuation
- Forward P/E
- —
- PEG ratio
- —
- P/B
- 1.93
- P/S (TTM)
- 6266.19
- EV/EBITDA
- -3.51
Profitability & growth
- ROE (TTM)
- -46.6%
- Operating margin
- 0.0%
- Revenue growth YoY
- 0.0%
- Dividend yield
- —
- Beta
- 1.57
Last earnings
Mar 23, 2026 · Estimate $-2.80 · Reported $-0.03
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About USBC, Inc.
Company profileUS BioTec, Inc. engages in the development, manufacture, marketing, and distribution of bio-degradable, nontoxic, and noncarcinogenic products in the United States. The company is headquartered in Gleason, Tennessee.
Classification
- Sector
- Technology
- Exchange
- NYSE MKT
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 300 E 2ND STREET, RENO, NV
- Fiscal year end
- September
- Latest quarter
- Dec 31, 2025
Market cap$168.8M
Shares outstanding$388.1M
52W high$5.36
52W low$0.31
Educational content · Not investment advice or recommendations
We're educators, not advisors. Your decisions are your own. Disclaimer
Balanced Agent
The Thinking Companion
I'm your AI thinking companion for the markets — I can help you explore and learn, but I'm not a financial advisor. Everything here is educational. Disclaimer
Balanced Agent